NCT06587737View on ClinicalTrials.gov

Colchicine for the Reduction of Dependency and Vascular Events After an Acute Intracerebral Hemorrhage

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

1,125

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

June 30, 2028

Study Completion Date

June 30, 2028

Conditions
ColchicineICH - Intracerebral HemorrhageStrokeDependence
Interventions
DRUG

Colchicine 0.5 MG

colchicine 0.5mg once-daily

DRUG

Placebo

matching placebo, lacking active ingredient, once-daily

Sponsors
All Listed Sponsors
lead

Population Health Research Institute

OTHER